Works in Pharmaceuticals (14248247), 2020, Vol 13, Issue 11


Results: 90
    1

    Logic Gates Based on DNA Aptamers.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 417, doi. 10.3390/ph13110417
    By:
    • Andrianova, Mariia;
    • Kuznetsov, Alexander
    Publication type:
    Article
    2
    3

    Secretory Phospholipase A 2 -IIA Protein and mRNA Pools in Extracellular Vesicles of Bronchoalveolar Lavage Fluid from Patients with Early Acute Respiratory Distress Syndrome: A New Perception in the Dissemination of Inflammation?

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 415, doi. 10.3390/ph13110415
    By:
    • Papadopoulos, Stylianos;
    • Kazepidou, Eleftheria;
    • Antonelou, Marianna H.;
    • Leondaritis, George;
    • Tsapinou, Alexia;
    • Koulouras, Vasilios P.;
    • Avgeropoulos, Apostolos;
    • Nakos, George;
    • Lekka, Marilena E.
    Publication type:
    Article
    4

    VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 414, doi. 10.3390/ph13110414
    By:
    • Gal, Jocelyn;
    • Milano, Gérard;
    • Brest, Patrick;
    • Ebran, Nathalie;
    • Gilhodes, Julia;
    • Llorca, Laurence;
    • Dubot, Coraline;
    • Romieu, Gilles;
    • Desmoulins, Isabelle;
    • Brain, Etienne;
    • Goncalves, Anthony;
    • Ferrero, Jean-Marc;
    • Cottu, Paul-Henri;
    • Debled, Marc;
    • Tredan, Olivier;
    • Chamorey, Emmanuel;
    • Merlano, Marco Carlo;
    • Lemonnier, Jérôme;
    • Etienne-Grimaldi, Marie-Christine;
    • Pierga, Jean-Yves
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Later-Line Treatment with Lorlatinib in ALK - and ROS1 -Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 371, doi. 10.3390/ph13110371
    By:
    • Hochmair, Maximilian J.;
    • Fabikan, Hannah;
    • Illini, Oliver;
    • Weinlinger, Christoph;
    • Setinek, Ulrike;
    • Krenbek, Dagmar;
    • Prosch, Helmut;
    • Rauter, Markus;
    • Schumacher, Michael;
    • Wöll, Ewald;
    • Wass, Romana;
    • Brehm, Elmar;
    • Absenger, Gudrun;
    • Bundalo, Tatjana;
    • Errhalt, Peter;
    • Urban, Matthias;
    • Valipour, Arschang
    Publication type:
    Article
    48
    49
    50